APAF1 and non-small cell lung carcinoma: Direct repression of apoptotic peptidase activating factor 1 (APAF1) by miR-221/222 and inhibition of BCL2 like 11 (BIM) by miR-30b/c leads to gefitinib resistance in NSCLC [100].